A carregar...

Iterative Design of Emetine-Based Prodrug Targeting Fibroblast Activation Protein (FAP) and Dipeptidyl Peptidase IV DPPIV Using a Tandem Enzymatic Activation Strategy

BACKGROUND. There is an urgent need to develop new agents for treating metastatic prostate cancer to overcome multiple drug resistance to the current standard targeted cancer therapy. Emetine is a highly cytotoxic natural product protein synthesis inhibitor, which is toxic to all cell types. Its cyt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate
Main Authors: Akinboye, Emmanuel S., Brennen, W. Nathaniel, Rosen, D. Marc, Bakare, Oladapo, Denmeade, Samuel R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6432629/
https://ncbi.nlm.nih.gov/pubmed/26835873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!